Life Sciences Discussion + Networking
Mon, Aug 19
|Toronto
Join us for our next event featuring Liran Belenzon, CEO of BenchSci, as he delves into groundbreaking advancements in life sciences. Network with industry leaders and discover how cutting-edge AI technology is revolutionizing drug discovery and development.
Time & Location
Aug 19, 2024, 6:00 p.m. – 9:00 p.m.
Toronto, 100 King St W Suite 1600, Toronto, ON M5X 1G5, Canada
About the event
Join us on Monday, August 19th as we welcome Liran Belenzon, the CEO of BenchSci for our Life Sciences event. We will be having a fireside chat hosted by Dennis Kavelman, a partner at Inovia Capital and former COO of Research in Motion.
BenchSci is a biomedical artificial intelligence company Liran co-founded while completing his MBA at Rotman in 2016.
BenchSci has gone from four co-founders to an over 400-strong operation that has raised more than $218 million from top investors, including Google’s Gradient Ventures and F-Prime. Today, BenchSci’s software is used by 16 of the top 20 pharmaceutical companies and by over 50,000 scientists working at more than 4,500 leading research centers worldwide.
While at Rotman, Liran worked in the Creative Destruction Lab (CDL) where he met BenchSci co-founders Tom Leung, David Chen, and Elvis Wianda. The trio of PhDs was working on a project exploring the use of machine…